No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Base Sequence
-
Dasatinib / therapeutic use*
-
Female
-
Gene Expression
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Intracellular Signaling Peptides and Proteins / genetics
-
Intracellular Signaling Peptides and Proteins / metabolism
-
Middle Aged
-
Oncogene Proteins, Fusion / antagonists & inhibitors
-
Oncogene Proteins, Fusion / genetics*
-
Oncogene Proteins, Fusion / metabolism
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
-
Proto-Oncogene Proteins c-abl / antagonists & inhibitors
-
Proto-Oncogene Proteins c-abl / genetics
-
Proto-Oncogene Proteins c-abl / metabolism
-
Translocation, Genetic
-
Transplantation, Homologous
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Intracellular Signaling Peptides and Proteins
-
Oncogene Proteins, Fusion
-
RCSD1 protein, human
-
Proto-Oncogene Proteins c-abl
-
Dasatinib